. 2017 Jan 10;2017:9684193. doi: 10.1155/2017/9684193

Table 4.

ΔE values of tested restorative materials with pediatric drugs (mean ± sd).

Restorative materials	Composite	Compomer	Glass ionomer
Restorative materials	ΔE (mean ± sd)	ΔE (mean ± sd)	ΔE (mean ± sd)
Drug/brand name
Augmentin	5.9 ± 2.12^a	2.29 ± 0.92^B,b	3.82 ± 1.61^c
Macrol	5.63 ± 2.01^a	2.23 ± 1.98^C,b	2.34 ± 0.81^b
Cefaks	6.40 ± 2.2^a	4.67 ± 1.3^c	2.4 ± 0.81^b
Calpol 6 plus	6.64 ± 0.68^a	3.90 ± 3.01^b	2.57 ± 0.92^c
Dolven	5.30 ± 1.45^b	4.76 ± 3.41^A,c	2.08 ± 0.40^a
Keppra	5.68 ± 1.59^a	3.18 ± 1.56^b	2.72 ± 0.56^c
Ferrosanol B	6.55 ± 1.38^a	2.61 ± 2.03^b	2.17 ± 0.69^b
Ventolin	6.30 ± 1.76^a	2.09 ± 1.2^D,b	2.09 ± 0.48^b
Atarax	4.14 ± 1.06	3.1 ± 2.46	2.41 ± 1.02
Sudafed	6.07 ± 1.84^a	3.51 ± 2.34^b	3.13 ± 1.13^c

^∗Significant differences were only found in compomer group between pediatric drug comparisons (p^A-B = 0.021; p^A–C = 0.018; p^A–D = 0.013); no differences were obtained in other pairwise comparisons p > 0.05.

^∗Significant differences were found in Augmentin group; composite-compomer (p^a-b = 0.01) and composite-glass ionomer cement (p^a–c = 0.04), in Macrol group; between composite-compomer/glass ionomer (p^a-b = 0.002), in Cefaks group; composite-glass ionomer cement (p^a-b = 0.01) and compomer-glass ionomer cement (p^b-c = 0.033) in Calpol 6 plus group; between composite-compomer (p^a-b = 0.011) and composite-glass ionomer (p^a–c < 0.001), in Dolven group; between glass ionomer-composite (p^a-b = 0.003) and glass ionomer-compomer (p^a–c = 0.013), in Keppra group; composite-compomer (p^a-b = 0.02) and composite-glass ionomer cement (p^a–c = 0.006), in Ferrosanol B group; between composite- compomer/glass ionomer (p^a-b < 0.001) in Ventolin group; between composite-compomer/glass ionomer (p^a-b < 0.001) in Sudafed group; composite-compomer (p^a-b = 0.009) and composite-glass ionomer cement (p^a–c = 0.014). No differences were found in Atarax group (p > 0.05).